These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
4. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)? Spechler SJ Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402 [TBL] [Abstract][Full Text] [Related]
5. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus. Jankowski JA; Anderson M Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468 [TBL] [Abstract][Full Text] [Related]
6. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204 [TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms. Toruner M; Soykan I; Ensari A; Kuzu I; Yurdaydin C; Ozden A J Gastroenterol Hepatol; 2004 May; 19(5):535-40. PubMed ID: 15086597 [TBL] [Abstract][Full Text] [Related]
11. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus. Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565 [TBL] [Abstract][Full Text] [Related]
12. Barrett's esophagus: the long and the short of it. Nandurkar S; Talley NJ Am J Gastroenterol; 1999 Jan; 94(1):30-40. PubMed ID: 9934728 [TBL] [Abstract][Full Text] [Related]
13. Management of Barrett's esophagus free of dysplasia. DeMeester SR Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346 [TBL] [Abstract][Full Text] [Related]
14. Surgical options and outcomes in Barrett's esophagus. Zaninotto G; Rizzetto C Curr Opin Gastroenterol; 2007 Jul; 23(4):452-5. PubMed ID: 17545785 [TBL] [Abstract][Full Text] [Related]
15. The rationale for screening and surveillance of Barrett's metaplasia. Wani S; Sharma P Best Pract Res Clin Gastroenterol; 2006; 20(5):829-42. PubMed ID: 16997164 [TBL] [Abstract][Full Text] [Related]
16. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of Barrett's esophagus: An observational study from a gastroenterology clinic. Herrera Elizondo JL; Monreal Robles R; García Compean D; González Moreno EI; Borjas Almaguer OD; Maldonado Garza HJ; González González JA Rev Gastroenterol Mex; 2017; 82(4):296-300. PubMed ID: 28687434 [TBL] [Abstract][Full Text] [Related]
18. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma. Thrift AP Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Wani S; Rubenstein JH; Vieth M; Bergman J Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561 [TBL] [Abstract][Full Text] [Related]
20. Endoscopic screening and surveillance for Barrett's esophagus--clinical implications. Barr H; Kendall C; Bazant-Hegemark F; Moayyedi P; Shetty G; Stone N MedGenMed; 2006 Jun; 8(2):66. PubMed ID: 16926805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]